File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0016-5085(91)90667-A
- Scopus: eid_2-s2.0-0025877177
- PMID: 2019372
- WOS: WOS:A1991FL37500024
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Ceftriaxone-associated gallbladder sludge: Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate
Title | Ceftriaxone-associated gallbladder sludge: Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate |
---|---|
Authors | |
Issue Date | 1991 |
Publisher | WB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/gastro |
Citation | Gastroenterology, 1991, v. 100 n. 6, p. 1665-1670 How to Cite? |
Abstract | Ceftriaxone, a third-generation cephalosporin, is partially excreted into bile. With its clinical use, the formation of gallbladder sludge detected by ultrasonography has been reported. Four surgical specimens were examined and no gallstones were found. Instead, fine precipitates of 20-250 μm were present. Microscopically, there was a small number of cholesterol monohydrate crystals and bilirubin granules among an abundant amount of granular-crystalline material that was not morphologically cholesterol monohydrate crystals. The chemical composition of the precipitates (n = 4) was determined. There was a small amount of cholesterol (1.7% ± 0.8%) and bilirubin (13.9% ± 0.74%). The major component of the precipitate was a residue. On further analysis using thin-layer chromatography, high-performance liquid chromatography, and electron microprobe analysis, the residue was identified as a calcium salt of ceftriaxone. The residue also had identical crystal morphology and chromatographic elution profile as authentic calcium-ceftriaxone standards. It is concluded that ceftriaxone, after excretion and being concentrated in the gallbladder bile, can form a precipitate. The major constituent has been identified as a ceftriaxone-calcium salt. |
Persistent Identifier | http://hdl.handle.net/10722/175659 |
ISSN | 2023 Impact Factor: 25.7 2023 SCImago Journal Rankings: 7.362 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, HZ | en_US |
dc.contributor.author | Lee, SP | en_US |
dc.contributor.author | Schy, AL | en_US |
dc.date.accessioned | 2012-11-26T09:00:19Z | - |
dc.date.available | 2012-11-26T09:00:19Z | - |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | Gastroenterology, 1991, v. 100 n. 6, p. 1665-1670 | en_US |
dc.identifier.issn | 0016-5085 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/175659 | - |
dc.description.abstract | Ceftriaxone, a third-generation cephalosporin, is partially excreted into bile. With its clinical use, the formation of gallbladder sludge detected by ultrasonography has been reported. Four surgical specimens were examined and no gallstones were found. Instead, fine precipitates of 20-250 μm were present. Microscopically, there was a small number of cholesterol monohydrate crystals and bilirubin granules among an abundant amount of granular-crystalline material that was not morphologically cholesterol monohydrate crystals. The chemical composition of the precipitates (n = 4) was determined. There was a small amount of cholesterol (1.7% ± 0.8%) and bilirubin (13.9% ± 0.74%). The major component of the precipitate was a residue. On further analysis using thin-layer chromatography, high-performance liquid chromatography, and electron microprobe analysis, the residue was identified as a calcium salt of ceftriaxone. The residue also had identical crystal morphology and chromatographic elution profile as authentic calcium-ceftriaxone standards. It is concluded that ceftriaxone, after excretion and being concentrated in the gallbladder bile, can form a precipitate. The major constituent has been identified as a ceftriaxone-calcium salt. | en_US |
dc.language | eng | en_US |
dc.publisher | WB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/gastro | en_US |
dc.relation.ispartof | Gastroenterology | en_US |
dc.subject.mesh | Bile - Chemistry | en_US |
dc.subject.mesh | Calcium - Metabolism | en_US |
dc.subject.mesh | Ceftriaxone - Adverse Effects - Metabolism | en_US |
dc.subject.mesh | Chemical Precipitation | en_US |
dc.subject.mesh | Cholelithiasis - Ultrasonography | en_US |
dc.subject.mesh | Chromatography, High Pressure Liquid | en_US |
dc.subject.mesh | Chromatography, Thin Layer | en_US |
dc.subject.mesh | Diagnosis, Differential | en_US |
dc.subject.mesh | Electron Probe Microanalysis | en_US |
dc.subject.mesh | Gallbladder - Ultrasonography | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Microscopy, Electron, Scanning | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Spectrophotometry, Infrared | en_US |
dc.title | Ceftriaxone-associated gallbladder sludge: Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lee, SP: sumlee@hku.hk | en_US |
dc.identifier.authority | Lee, SP=rp01351 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0016-5085(91)90667-A | - |
dc.identifier.pmid | 2019372 | - |
dc.identifier.scopus | eid_2-s2.0-0025877177 | en_US |
dc.identifier.volume | 100 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.spage | 1665 | en_US |
dc.identifier.epage | 1670 | en_US |
dc.identifier.isi | WOS:A1991FL37500024 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Park, HZ=7601570519 | en_US |
dc.identifier.scopusauthorid | Lee, SP=7601417497 | en_US |
dc.identifier.scopusauthorid | Schy, AL=6604068075 | en_US |
dc.identifier.issnl | 0016-5085 | - |